Position
Chief Financial Officer
Company
Gyre Therapeutics
San DiegoManufacturingBiotechnologyHealthcareHealth CareTherapeuticsBiopharmaDescription
On October 16, 2026, Gyre Therapeutics, Inc. announced the appointment of Ying Luo, Ph.D., as Chief Executive Officer and Thomas Eastling as Chief Financial Officer. Both executives will continue to serve in their respective roles under newly established employment agreements
Quick answer
Gyre Therapeutics Appoints Ying Luo as CEO and Thomas Eastling as CFO (October 22, 2026). Gyre Therapeutics is based in San Diego, California, United States.
- Who is the new Chief Financial Officer at Gyre Therapeutics?
- Gyre Therapeutics named Thomas Eastling Chief Financial Officer, announced October 22, 2026.
- What did Gyre Therapeutics announce on October 22, 2026?
- On October 16, 2026, Gyre Therapeutics, Inc. announced the appointment of Ying Luo, Ph.D., as Chief Executive Officer and Thomas Eastling as Chief Financial Officer.
- What does Gyre Therapeutics do?
- Gyre Therapeutics is an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic diseases.
- Where is Gyre Therapeutics based?
- Gyre Therapeutics is based in San Diego, California, United States.
- Which similar companies made leadership changes around the same time?
- AbbVie Inc. (November 2, 2026), Retension Pharmaceuticals (October 23, 2026), Tempest Therapeutics (October 19, 2026) and Verastem Oncology (October 14, 2026) also announced leadership changes within 45 days of Gyre Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
- Retension Pharmaceuticals Appoints Robert Wong as Chief Accounting Officer (October 23, 2026)
- Tempest Therapeutics Appoints John Frederick as Class III Director (October 19, 2026)
- Verastem Oncology Appoints Michael P. Bailey as Chief Executive Officer (October 14, 2026)
- Jazz Pharmaceuticals Announces Transition in Leadership (October 9, 2026)
- Absci Corporation Appoints Gerry Muhle as Chief Commercial Officer (November 12, 2026)
Who to call at Gyre Therapeutics, and when
A new leader at Gyre Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Gyre Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Gyre Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Gyre Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Gyre Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Gyre Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.